Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program aims to improve dental care in schizophrenia patients

NCT ID NCT02512367

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a dental health education program for people with schizophrenia to see if it could improve their oral hygiene and quality of life. Participants were randomly assigned to either the education program or standard monitoring. The study lasted 12 months and included dental check-ups at the start, 6 months, and 12 months. Unfortunately, the trial was terminated early, so the results are limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dental care education program
What this could lead to
If successful, this program could help people with schizophrenia maintain better dental health and improve their overall well-being.
What could go wrong
The trial was terminated early with only 79 participants, so results are limited and may not be reliable. The program may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

79 people

The number who actually took part.

Started

Apr 2017

Finished

Oct 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with a confirmed diagnosis of schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM V) * Managed at a specialized establishment * Older than 18 years. * who have provided written informed consent to take part in the study Exclusion Criteria: * Fully hospitalized patients * Patients who are unstable from a psychiatric poit of view or who suffer from delirium. * Subjects with less than one incisor, canine, premolar and molar on each hemi-arch * Patients with a risk of infectious endocarditis or a major risk of superinfection * Patients on long-term treatment with antibiotics (Impact of antibiotherapy on oral flora) * Patients treated with chemotherapy * Pregnant or breastfeeding women * Patients without National Health Insurance cover. * Poor written and/or oral comprehension of the French language

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Schizophrenia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Esquirol

    Limoges, 87025, France

  • CH La Chartreuse

    Dijon, 21000, France

  • CH Le Vinatier

    Bron, 69678, France

  • CH de Jury

    Metz, 57073, France

  • CH de Novillars

    Novillars, 25220, France

  • CH de Saint-Rémy et Nord Franche Comté

    Saint-Rémy, 70160, France

  • CH de Semur en Auxois

    Semur-en-Auxois, 21140, France

  • CHS de la Savoie

    Chambéry, 73011, France

  • CHS du Jura

    Dole, 39108, France

  • CHU de Besançon

    Besançon, 25000, France

  • CHU de DIJON

    Dijon, 21079, France

  • Chs Epsan

    Brumath, 67173, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.